Carisma Therapeutics OverviewCarisma Therapeutics Net Income
Profitability analysis for CARM.
Quarterly Net Income
$44.72M
↑ 452.05% YoY
As of Sep 2025
Annual Net Income (TTM)
$8.04M
↑ 112.61% YoY
Trailing 12 months ending Sep 2025
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...